TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis

Abstract

TET2 mutations are frequent in myeloid malignancies and in elderly individuals with or without cytopenia. Here, the authors analyse the association between TET2 mutations and methylation changes in healthy elderly twins and patients with cytopenia and compare them to those from leukemia.